Showing results (1071-1080 of 4,542) with videos related to

Sort By:
Pageof 455
Neoplasma|January 22, 2024
CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signalingZhi Wang, Tao Zhou, Xubo Chen, et al.
Neoplasma|January 22, 2024
Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution studyTian Wang, Jie Wang, Tianci Tang, et al.
Neoplasma|January 22, 2024
CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinomaXinlin Yang, Miao Zhang, Wei Xia, et al.
Neoplasma|September 13, 2024
Association between glutathione S-transferases M1 expression and treatment outcome in germ cell tumor patientsMichal Mego, Katarina Kalavska, Samuel Horak, et al.
Neoplasma|May 12, 2025
IL4I1 knockdown inhibits the epithelial-mesenchymal transition process in glioma via downregulation of the JAK2/STAT3 signaling pathwayJianwei Zhuo, Tong Wang, Ting Lu, et al.
Neoplasma|May 12, 2025
EIF4E promotes gefitinib resistance in non-small cell lung cancer by activating the Wnt/β-catenin pathwayBo Zhang, Jiani Zhu, Zixian Jin, et al.
Neoplasma|March 31, 2025
20(S)-ginsenoside Rg3 induced the necroptosis of prostate cancer cells via ROS overproductionYanfei Peng, Yaping Guo, Shuwu Zhao, et al.
Neoplasma|March 31, 2025
Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancerBeibei Chen, Huichen Zhao, Huihui Hu, et al.
Neoplasma|March 31, 2025
Inhibition of enzymatic activity of HRD1 results in death of cells derived from glioblastoma multiforme, neuroblastoma, and normal astrocytesJaroslava Guzikova, Monika Liskova, Lubos Hudak, et al.
Neoplasma|May 20, 2024
Copy number variations in malignant melanoma: genomic regions, biomarkers, and therapeutic targetsEva Lukáčová, Ondrej Pös, Eva Túryová, et al.
Pageof 455